Bavarian Nordic wins USD 97 million BARDA option for freeze-dried Jynneos supply

Bitwise Avalanche ETF

Bitwise Avalanche ETF

BAVA

0.00
  • Bavarian Nordic won exercised contract options worth USD 97 million from BARDA under an existing U.S. government agreement to manufacture bulk vaccine and supply freeze-dried JYNNEOS smallpox doses.
  • Options secure remaining doses under original 11.5 million-dose order; freeze-dried doses slated for manufacture and delivery in 2027.
  • Bulk vaccine order aims to replace bulk used for liquid-frozen doses supplied during 2022-2023 mpox outbreak; bulk invoicing expected in 2026.
  • Public Preparedness contracts secured for 2026 now about DKK 2 billion; 2026 Public Preparedness revenue view raised to DKK 2.3 billion-DKK 2.5 billion.
  • 2026 total revenue guidance lifted to DKK 5.5 billion-DKK 5.7 billion; EBITDA margin seen at about 28%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bavarian Nordic A/S published the original content used to generate this news brief on May 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.